Biochemical Engineering

Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will Begin In July

Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will Begin In July

2nd June 2020

Dr Anthony Fauci said the Phase 3 trial of Moderna’s experimental COVID-19 vaccine will begin in July and include study of 30,000 patients who will be as young as 18 and include elderly Americans as well. Fauci said the trial will include primarily U.S. sites, but also include international sites enrolling 30,000 individuals in a “randomized placebo” controlled trial of Moderna’s vaccine against the Coronavirus strain Covid-19. Source: Forbes.com 2/6/2020


Back to group news